High sensitivity CRP levels predict atrial tachyarrhythmias in rheumatic mitral stenosis

Annals of Noninvasive Electrocardiology

Volumn 13, Issue 1, 2008, Pages 31-38

  Ucer, Ekrem ^a,b   Gungor, Baris ^a   Erdinler, Izzet Celal ^a   Akyol, Ahmet ^a   Alper, Ahmet Taha ^a   Eksik, Abdurrahman ^a   Cakmak, Nazmiye ^a   Gurkan, Kadir ^a   Ulufer, Tanju ^a  

^a Dr Siyami Ersek Thoracic and Cardiovascular Training and Research Hospital   (Turkey)

^b NONE   (Turkey)

Author keywords

Atrial fibrillation; hs CRP; Mitral stenosis

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; DISEASE CLASSIFICATION; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM VOLUME; HEART VOLUME; HUMAN; LOGISTIC REGRESSION ANALYSIS; MALE; MITRAL VALVE REPAIR; MITRAL VALVE STENOSIS; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PRIORITY JOURNAL; RHEUMATIC HEART DISEASE; SINUS RHYTHM; STATISTICAL SIGNIFICANCE; SUPRAVENTRICULAR TACHYCARDIA;

ADULT; ARRHYTHMIAS, CARDIAC; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHRONIC DISEASE; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART ATRIA; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MITRAL VALVE STENOSIS; MONITORING, PHYSIOLOGIC; ODDS RATIO; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RHEUMATIC DISEASES; SENSITIVITY AND SPECIFICITY;

EID: 38549087931     PISSN: 1082720X     EISSN: 1542474X     Source Type: Journal    
DOI: 10.1111/j.1542-474X.2007.00198.x     Document Type: Article

References (25)

1. Carabello BA. Contemporary reviews in cardiovascular medicine: Modern management of mitral stenosis. Circulation 2005 112 : 432 437.
2. Krasuski RA, Bush A, Kay JE, et al. C-reactive protein elevation independently influences the procedural success of percutaneous balloon mitral valve commissurotomy. Am Heart J 2003 146 (6 1099 1104.
3. Golbasi Z, Ucar O, Keles T, et al. Increased levels of high sensitive C-reactive protein in patients with chronic rheumatic valve disease: Evidence of ongoing inflammation. Eur J Heart Fail 2002 4 (5 593 595.
4. Krasuski RA, Assar MD, Wang A, et al. Usefulness of percutaneous balloon mitral commissurotomy in preventing the development of atrial fibrillation in patients with mitral stenosis. Am J Cardiol 2004 93 (7 936 939.
5. Bruins P, te Velthuis H, Yazdanbakhsh AP, et al. Activation of the complement system during and after cardiopulmonary bypass surgery: Postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 1997 96 : 3542 3548.
6. Psychari SN, Apostolou TS, Sinos L, et al. Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation. Am J Cardiol 2005 95 : 764 767.
7. Gaudino M, Andreotti F, Zamparelli R, et al. The 2174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication? Circulation 2003 108 : 195 199.
8. Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001 104 (24 2886 2891.
9. Ramsdale DR, Arumugam N, Singh SS, et al. Holter monitoring in patients with mitral stenosis and sinus rhythm. Eur Heart J 1987 8 (2 164 170.
10. Chiu-Braga YY, Hayashi SY, Schafranski M, et al. Further evidence of inflammation in chronic rheumatic valve disease (CRVD): High levels of advanced oxidation protein products (AOPP) and high sensitive C-reactive protein (hs-CRP). Int J Cardiol 2005 Epub ahead of print J, Panaretou M. C-reactive protein and paroxysmal atrial fibrillation: Evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation. Acta Cardiol 2001 56 (6 375 380.
11. Kaplan MH, Volanakis JE. Interaction of C-reactive protein complexes with the complement system. J Immunol 1974 112 (6 2135 2147.
12. Volanakis JE, Wirtz KW. Interaction of C-reactive protein with artificial phosphatidylcholine bilayers. Nature 1979 281 (5727 155 157.
13. Camm AJ, Savelieva I, Bharati S. Atrial tachycardia, flutter, and fibrillation. In Saksena S, Camm AJ (eds Electrophysiological Disorders of the Heart. Philadelphia, Elsevier Churchill Livingstone, 2005, pp. 283 364.
14. Sata N, Hamada N, Horinouchi T, et al. C-reactive protein and atrial fibrillation. Is inflammation a consequence or a cause of atrial fibrillation? Jpn Heart J 2004 45 (3 441 445.
15. Abe S, Matsubara T, Hori T, et al. Effect of percutaneous transvenous mitral commissurotomy for the preservation of sinus rhythm in patients with mitral stenosis. J Cardiol 2001 38 (1 29 34.
16. Fuster V, Ryden LE, Asinger RW, et al. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for practice guidelines and policy conferences (committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J 2001 22 (20 1852 1923.
17. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003 107 : 499 511.
18. Wang Y, Gutman JM, Heilbron D, et al. Atrial volume in a normal adult population by two-dimensional echocardiography. Chest 1984 86 : 595 601.
19. Bonow RO, Carabello BA, Chatterjee K, et al. 2006 Guidelines for the management of patients with valvular heart disease a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the society of cardiovascular anesthesiologists endorsed by the society for cardiovascular angiography and interventions and the society of thoracic surgeons. J Am Coll Cardiol 2006 48 (3 e1 e148.
20. Coulshed N, Epstein EJ, McKendrick CS, et al. Systemic embolism in mitral valve disease. Br Heart J 1970 32 (1 26 34.
21. Casella L, Abelmann WH, Ellis LB. Patients with mitral stenosis and systemic emboli; Hemodynamic and clinical observations. Arch Intern Med 1964 114 : 773 781.
22. Ellis LB, Harken DE. Arterial embolization in relation to mitral valvuloplasty. Am Heart J 1961 62 : 611 620.
23. Kellogg F, Lu CK, Fishman IW, et al. Systemic and pulmonary emboli before and after mitral commissurotomy. Circulation 1961 24 : 263 266.
24. Primatesta P, Falaschetti E, Poulter NR. Influence of hormone replacement therapy on C-reactive protein: Population-based data. J Cardiovasc Risk 2003 10 (1 57 60.
25. Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002 347 (20 1557 1565.